9,10-dihydroxy-7,8-epoxy-7,8,9,10-tetrahydro-3-methylcholanthrene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 157306 |
| MeSH ID | M0114851 |
| Synonym |
|---|
| indeno(7',1':6,7,8)phenanthro(3,4-b)oxirane-2,3-diol, 1a,2,3,6,7,11c-hexahydro-8-methyl-, (1as-(1a-alpha,2-beta,3-alpha,11c-alpha))- |
| 3-mca-anti-9,10-diol-7,8-epoxide |
| 9,10-dihydroxy-7,8-epoxy-7,8,9,10-tetrahydro-3-methylcholanthrene |
| indeno(7',1':6,7,8)phenanthro(3,4-b)oxirene-2,3-diol, 1a,2,3,6,7,11c-hexahydro-8-methyl-, (1as-(1aalpha,2beta,3alpha,11calpha))- |
| 79647-25-9 |
| 3-methylcholanthrene-9,10-dihydrodiol-7,8-epoxide |
| DTXSID301000644 |
| 8-methyl-1a,2,3,6,7,11c-hexahydrocyclopenta[7,8]tetrapheno[1,2-b]oxirene-2,3-diol |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||